secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orchestra BioMed Holdings, Inc. (OBIO)
CIK:        0001814114
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001104659-25-073641
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orchestra BioMed raises ~$56M via public offering and private placement; grants warrant
--------------------------------------------------------------------------------

- Public offering of 9,413,637 shares at $2.75/sh + pre-funded warrants for 5,136,363 shares at $2.7499; gross $40M.
- Underwriters granted 30-day option for up to 2,182,500 additional shares at same price.
- Concurrent private placement: 5,895,608 shares to Ligand and Medtronic affiliate for ~$16.2M.
- Ligand receives warrant for up to 2M shares at $3.67, issued upon closing of placement.
- Proceeds to fund AVIM therapy BACKBEAT study, Virtue SAB program/trial, and general corporate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1814114/000110465925073641/0001104659-25-073641-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1814114/000110465925073641/tm2522158d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-073641

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer